China Universal Asset Management Co., Ltd. Immunocore Holdings PLC Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 8,393 shares of IMCR stock, worth $253,132. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,393
Previous 7,433
12.92%
Holding current value
$253,132
Previous $231,000
6.93%
% of portfolio
0.02%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding IMCR
# of Institutions
124Shares Held
35.9MCall Options Held
79.9KPut Options Held
46.2K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.7MShares$202 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$147 Million2.34% of portfolio
-
Primecap Management CO Pasadena, CA2.67MShares$80.5 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.19MShares$66 Million0.01% of portfolio
-
Tang Capital Management LLC San Diego, CA1.56MShares$46.9 Million3.45% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.32B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...